Pomalidomide-PEG-acetic acid is a novel chemical compound that is currently being studied for its potential use in pharmaceutical research and development. It is a derivative of Pomalidomide, a drug that has been approved for the treatment of multiple myeloma, a type of blood cancer.
Pomalidomide-PEG-acetic acid is a modified form of Pomalidomide that has been chemically modified with polyethylene glycol (PEG) and acetic acid. This modification alters the properties of the drug, allowing for improved solubility, stability, and bioavailability.
Pomalidomide-PEG-acetic acid
| Cat# | Name | Structure | Pricing |
|---|---|---|---|
| AP12386 | Pomalidomide-PEG2-acetic acid | Pricing | |
| AP12391 | Pomalidomide-PEG3-acetic acid | Pricing | |
| AP12392 | Pomalidomide-PEG4-acetic acid | Pricing |
